Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2017 May 15;64(10):1396-1405.
doi: 10.1093/cid/cix124.

Outcome and Treatment of Nocardiosis After Solid Organ Transplantation: New Insights From a European Study

David Lebeaux  1 , Romain Freund  2   3 , Christian van Delden  4   5 , Hélène Guillot  6 , Sierk D Marbus  7 , Marie Matignon  8 , Eric Van Wijngaerden  9 , Benoit Douvry  10 , Julien De Greef  11 , Fanny Vuotto  12 , Leïla Tricot  13 , Mario Fernández-Ruiz  14 , Jacques Dantal  15 , Cédric Hirzel  5   16 , Jean-Philippe Jais  2   3 , Veronica Rodriguez-Nava  17 , Frédérique Jacobs  18 , Olivier Lortholary  1 , Julien Coussement  18 ; European Study Group for Nocardia in Solid Organ Transplantation; European Study Group for Nocardia in Solid Organ Transplantation
Collaborators, Affiliations
Multicenter Study

Outcome and Treatment of Nocardiosis After Solid Organ Transplantation: New Insights From a European Study

David Lebeaux et al. Clin Infect Dis. .

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] Clin Infect Dis. 2017 Oct 15;65(8):1431-1433. doi: 10.1093/cid/cix563. Clin Infect Dis. 2017. PMID: 29017252 Free PMC article. No abstract available.

Abstract

Background: Solid organ transplant (SOT) recipients are at risk of nocardiosis, a rare opportunistic bacterial infection, but prognosis and outcome of these patients are poorly defined. Our objectives were to identify factors associated with 1-year mortality after nocardiosis and describe the outcome of patients receiving short-course antibiotics (≤120 days).

Methods: We analyzed data from a multicenter European case-control study that included 117 SOT recipients with nocardiosis diagnosed between 2000 and 2014. Factors associated with 1-year all-cause mortality were identified using multivariable conditional logistic regression.

Results: One-year mortality was 10-fold higher in patients with nocardiosis (16.2%, 19/117) than in control transplant recipients (1.3%, 3/233, P < .001). A history of tumor (odds ratio [OR], 1.4; 95% confidence interval [CI], 1.1-1.8), invasive fungal infection (OR, 1.3; 95% CI, 1.1-1.5), and donor age (OR, 1.0046; 95% CI, 1.0007-1.0083) were independently associated with 1-year mortality. Acute rejection in the year before nocardiosis was associated with improved survival (OR, 0.85; 95% CI, 0.73-0.98). Seventeen patients received short-course antibiotics (median duration 56 [24-120] days) with a 1-year success rate (cured and surviving) of 88% and a 5.9% risk of relapse (median follow-up 49 [6-136] months).

Conclusions: One-year mortality was 10-fold higher in SOT patients with nocardiosis than in those without. Four factors, largely reflecting general medical condition rather than severity and/or management of nocardiosis, were independently associated with 1-year mortality. Patients who received short-course antibiotic treatment had good outcomes, suggesting that this may be a strategy for further study.

Keywords: Nocardia; mortality; opportunistic infections.; organ transplantation; prognosis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
One-year survival curves after diagnosis of post-solid organ transplantation nocardiosis. Survival was assessed using Kaplan-Meier curves and compared among groups using log-rank tests. A, Survival curves of patients with nocardiosis (n = 117) and matched control transplant recipients (n = 234). B–D, Survival curves among patients with nocardiosis according to the presence of invasive fungal infection (including Pneumocystis pneumonia) in the 6 months before nocardiosis (B), history of tumor defined as a nonmetastatic tumor (if active or initially treated in the 5 years before diagnosis of nocardiosis) or metastatic solid tumor (C), and episode of acute rejection in the year before nocardiosis (D). Abbreviations: AR, acute rejection; IFI, invasive fungal infection.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Brown-Elliott BA Brown JM Conville PS Wallace RJ Jr. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev 2006; 19:259–82. - PMC - PubMed
    1. Lebeaux D Morelon E Suarez F et al. Nocardiosis in transplant recipients. Eur J Clin Microbiol Infect Dis 2014; 33:689–702. - PubMed
    1. Husain S McCurry K Dauber J Singh N Kusne S. Nocardia infection in lung transplant recipients. J Heart Lung Transplant 2002; 21:354–9. - PubMed
    1. Poonyagariyagorn HK Gershman A Avery R et al. Challenges in the diagnosis and management of Nocardia infections in lung transplant recipients. Transpl Infect Dis 2008; 10:403–8. - PubMed
    1. Santos M Gil-Brusola A Morales P. Infection by Nocardia in solid organ transplantation: thirty years of experience. Transplant Proc 2011; 43:2141–4. - PubMed

Publication types

MeSH terms

Substances

-